Contact us
We invite you to join this KOL webinar featuring two globally recognized U.S. pulmonology experts to get their views on the data from REALITY and how eyonis™ LCS may impact lung cancer diagnostics and treatment practices in the real world. Panelists include Prof. Anil Vachani, from the Hospital of the University of Pennsylvania, and Prof. Javier Zulueta, from the Icahn School of Medicine at Mt Sinai. Fredrik Brag, CEO of Median Technologies, also will participate and summarize the final REALITY results, which are going to be submitted in H1 2025 to regulators for U.S. and EU marketing authorizations for eyonis™ LCS.